The inspection concluded without any observations and no Form 483 was issued.
Share price of Biocon gained nearly 1 percent in the early trade on Friday after USFDA inspection at Telangana unit.
The USFDA conducted a GMP inspection of company's APIs manufacturing facility at Telangana from December 12-14, 2018.
The inspection concluded without any observations and no Form 483 was issued.
The successful inspection of this site reflects our strong commitment to quality and cGMP compliance, company said.
At 09:17 hrs Biocon was quoting at Rs 651.80, up Rs 5.45, or 0.84 percent on the BSE.
The share touched its 52-week high Rs 718.35 and 52-week low Rs 508 on 26 September, 2018 and 18 December, 2017, respectively.
Currently, it is trading 9.26 percent below its 52-week high and 28.31 percent above its 52-week low.
GET ONE DAY FREE TRIAL>>>GOLD SILVER TIPS
No comments:
Post a Comment